Assessment of the capacity of the four selected recombinant misfolded PrP generated by PMSA to induce misfolding of PrP<sup>C</sup> from brain <i>in vitro.</i>

To predict the potential infectivity <i>in vivo</i> of the distinct PMSA products selected for further characterization (stMI-01 Dx, stMI-03 Dx, btMI-05 Dx and btMI-09 Dx), their capacity to induce misfolding of PrP<sup>C</sup> in brain homogenates of TgMoL108I animals, expressing 3-fold the mouse L108I PrP, was evaluated using PMCA. PMSA products were partially purified by ultracentrifugation through a density gradient, resulting in visible halos of proteic aggregates in all four samples. These purified fractions exhibited indistinguishable biochemical properties after proteinase K digestion and retained the same electrophoretic pattern as the original product. These purified fractions were used to seed a PMCA substrate based on TgMoL108I brain homogenate at 1:10 dilutions, and a 24 h PMCA reaction was performed (R1). Two additional serial PMCA rounds were conducted, with the second round (R2) seeded at 1:10 dilution using the product from the first round, and the third round (R3) utilizing a 1:10 dilution of the product form the second one. After the three serial PMCA rounds of 24 h, PrP<sup>Sc</sup> detection was carried out by proteinase K digestion and Western blotting (mAb Sha31 at a dilution of 1:4,000). A seeded tube at 1:10 but not submitted to PMCA is also included for each PMSA product, referred to as R0, to show the signal corresponding to the recombinant seed, slightly lower than the unglycosylated PrP<sup>C</sup> from brain. Finally, an unseeded tube was also included together with each PMSA product in every PMCA round, performing also serial passages as control for cross-contamination or spontaneous misfolding. All four recombinant seeds were able to misfold brain-derived PrP<sup>C</sup> from the first PMCA round, giving rise to the classical three-banded PrP<sup>Sc</sup> pattern, suggesting the potential infectivity of these preparations <i>in vivo</i>. PK: Proteinase K; NBH control: Normal brain homogenate from TgMoL108I. Mw: Molecular weight. (PDF)

Publication Details

Journal
Figshare
Published
2025-01-22
DOI
https://doi.org/10.1371/journal.ppat.1012890.s005
Primary Topic
Trace Elements in Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessment of the capacity of the four selected recombinant misfolded PrP generated by PMSA to induce misfolding of PrPC from brain in vitro.

Figshare
Trace Elements in Health
article

Assessment of the capacity of the four selected recombinant misfolded PrP generated by PMSA to induce misfolding of PrPC from brain in vitro.

article en

Abstract

To predict the potential infectivity <i>in vivo</i> of the distinct PMSA products selected for further characterization (stMI-01 Dx, stMI-03 Dx, btMI-05 Dx and btMI-09 Dx), their capacity to induce misfolding of PrP<sup>C</sup> in brain homogenates of TgMoL108I animals, expressing 3-fold the mouse L108I PrP, was evaluated using PMCA. PMSA products were partially purified by ultracentrifugation through a density gradient, resulting in visible halos of proteic aggregates in all four samples. These purified fractions exhibited indistinguishable biochemical properties after proteinase K digestion and retained the same electrophoretic pattern as the original product. These purified fractions were used to seed a PMCA substrate based on TgMoL108I brain homogenate at 1:10 dilutions, and a 24 h PMCA reaction was performed (R1). Two additional serial PMCA rounds were conducted, with the second round (R2) seeded at 1:10 dilution using the product from the first round, and the third round (R3) utilizing a 1:10 dilution of the product form the second one. After the three serial PMCA rounds of 24 h, PrP<sup>Sc</sup> detection was carried out by proteinase K digestion and Western blotting (mAb Sha31 at a dilution of 1:4,000). A seeded tube at 1:10 but not submitted to PMCA is also included for each PMSA product, referred to as R0, to show the signal corresponding to the recombinant seed, slightly lower than the unglycosylated PrP<sup>C</sup> from brain. Finally, an unseeded tube was also included together with each PMSA product in every PMCA round, performing also serial passages as control for cross-contamination or spontaneous misfolding. All four recombinant seeds were able to misfold brain-derived PrP<sup>C</sup> from the first PMCA round, giving rise to the classical three-banded PrP<sup>Sc</sup> pattern, suggesting the potential infectivity of these preparations <i>in vivo</i>. PK: Proteinase K; NBH control: Normal brain homogenate from TgMoL108I. Mw: Molecular weight. (PDF)

Figshare
Openalex Percentile: Top 46%
Trace Elements in Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.